The device, called CardiAQ, is a magnetocardiography imaging system. Magnetic sensors and AI allow physicians to detect abnormal heart rhythms and cardiac disease indicators, according to an Aug. 8 news release from SandboxAQ.
The device is mobile, noninvasive and contactless. It has the potential to “enable rapid and radiation-free visualization and assessment of the magnetic signals of the heart,” the release said.
Mayo Clinic will conduct a clinical research study with CardiAQ between 2024 and 2025. UCSF Medical Center in San Francisco and Mount Sinai West in New York City have previously conducted clinical studies with CardiAQ, according to the release.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
